ATE234620T1 - Verwendung von lithium-gluconat zur herstellung eines arzneimittels zur behandlung von herpes und seborrhoischer dermatitis - Google Patents
Verwendung von lithium-gluconat zur herstellung eines arzneimittels zur behandlung von herpes und seborrhoischer dermatitisInfo
- Publication number
- ATE234620T1 ATE234620T1 AT99941691T AT99941691T ATE234620T1 AT E234620 T1 ATE234620 T1 AT E234620T1 AT 99941691 T AT99941691 T AT 99941691T AT 99941691 T AT99941691 T AT 99941691T AT E234620 T1 ATE234620 T1 AT E234620T1
- Authority
- AT
- Austria
- Prior art keywords
- herpes
- treatment
- production
- lithium gluconate
- medicinal product
- Prior art date
Links
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 title abstract 3
- 229940071260 lithium gluconate Drugs 0.000 title abstract 3
- ZOTSUVWAEYHZRI-JJKGCWMISA-M lithium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Li+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O ZOTSUVWAEYHZRI-JJKGCWMISA-M 0.000 title abstract 3
- 201000004624 Dermatitis Diseases 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 206010062639 Herpes dermatitis Diseases 0.000 abstract 2
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 abstract 2
- 208000008742 seborrheic dermatitis Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9811025A FR2783424B1 (fr) | 1998-09-03 | 1998-09-03 | Utilisation du gluconate de lithium dans la fabrication d'un medicament pour le traitement de l'herpes et de la dermite seborrheique |
| PCT/FR1999/002108 WO2000013649A2 (fr) | 1998-09-03 | 1999-09-03 | Utilisation du gluconate de lithium dans la fabrication d'un medicament pour le traitement de l'herpes et de la dermite seborrheique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE234620T1 true ATE234620T1 (de) | 2003-04-15 |
Family
ID=9530089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99941691T ATE234620T1 (de) | 1998-09-03 | 1999-09-03 | Verwendung von lithium-gluconat zur herstellung eines arzneimittels zur behandlung von herpes und seborrhoischer dermatitis |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1107766B1 (de) |
| AT (1) | ATE234620T1 (de) |
| AU (1) | AU5521099A (de) |
| CA (1) | CA2341566C (de) |
| DE (1) | DE69906091T2 (de) |
| ES (1) | ES2193741T3 (de) |
| FR (1) | FR2783424B1 (de) |
| PT (1) | PT1107766E (de) |
| WO (1) | WO2000013649A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6416981B1 (en) | 2000-05-23 | 2002-07-09 | Nec Partnership | Production of gluconate salts |
| EP3871693A1 (de) * | 2005-09-27 | 2021-09-01 | Special Water Patents B.V. | Zusammensetzungen zur mundpflege |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8318912D0 (en) * | 1983-07-13 | 1983-08-17 | Horrobin D F | Compositions for treatment of skin/hair |
| GB8319766D0 (en) * | 1983-07-22 | 1983-08-24 | Graham N B | Controlled release device |
| GB9023701D0 (en) * | 1990-10-31 | 1990-12-12 | Efamol Holdings | Medical treatment |
| AU681629B2 (en) * | 1993-03-12 | 1997-09-04 | Keele University | Therapeutic compositions containing a lithium compound and silica |
-
1998
- 1998-09-03 FR FR9811025A patent/FR2783424B1/fr not_active Expired - Fee Related
-
1999
- 1999-09-03 DE DE69906091T patent/DE69906091T2/de not_active Expired - Lifetime
- 1999-09-03 AU AU55210/99A patent/AU5521099A/en not_active Abandoned
- 1999-09-03 EP EP99941691A patent/EP1107766B1/de not_active Expired - Lifetime
- 1999-09-03 PT PT99941691T patent/PT1107766E/pt unknown
- 1999-09-03 WO PCT/FR1999/002108 patent/WO2000013649A2/fr not_active Ceased
- 1999-09-03 AT AT99941691T patent/ATE234620T1/de active
- 1999-09-03 CA CA002341566A patent/CA2341566C/fr not_active Expired - Fee Related
- 1999-09-03 ES ES99941691T patent/ES2193741T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2341566C (fr) | 2009-11-24 |
| FR2783424B1 (fr) | 2002-10-04 |
| DE69906091T2 (de) | 2003-11-20 |
| AU5521099A (en) | 2000-03-27 |
| WO2000013649A2 (fr) | 2000-03-16 |
| CA2341566A1 (fr) | 2000-03-16 |
| EP1107766B1 (de) | 2003-03-19 |
| WO2000013649A3 (fr) | 2000-07-20 |
| FR2783424A1 (fr) | 2000-03-24 |
| DE69906091D1 (de) | 2003-04-24 |
| EP1107766A2 (de) | 2001-06-20 |
| PT1107766E (pt) | 2003-08-29 |
| ES2193741T3 (es) | 2003-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69428268D1 (de) | Verwendung von lokalanaesthetika zur herstellung eines arzneimittels zur behandlung von bronchialasthma | |
| ATE324884T1 (de) | Verwendung von gamma-linolensäure oder dihomogammalinolensäure zur herstellung eines medikaments zur behandlung von huntington's chorea | |
| ATE231885T1 (de) | Verwendung von komplement-inhibitoren zur herstellung eines arzneimittels zur prophylaxe und therapie von entzündlichen darm- und hauterkrankungen sowie purpura | |
| DE68902649D1 (de) | Lokal anzuwendende arzneizubereitung zur behandlung von entzuendungserkrankungen. | |
| SE9401406D0 (sv) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
| ATE203403T1 (de) | Verwendung von prolin als einziger therapeutischer wirkstoff zur herstellung eines arzneimittels zur behandlung von rheumatischen erkrankungen und von chronischen und traumatisch bedingten schmerzzuständen | |
| DE3876877D1 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| DE68912195D1 (de) | Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis. | |
| DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
| ATE172117T1 (de) | Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten | |
| ATE274349T1 (de) | Verwendung von fruktan zur herstellung eines arzneimittels zur vorbeugung und behandlung von dickdarmkrebs | |
| DE59409394D1 (de) | Therapeutisches system zur behandlung der psoriasis | |
| HUP9902029A2 (hu) | Sebgyógyulási folyamat szabályozása | |
| DE3850154D1 (de) | Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression. | |
| ATE234620T1 (de) | Verwendung von lithium-gluconat zur herstellung eines arzneimittels zur behandlung von herpes und seborrhoischer dermatitis | |
| ATE192929T1 (de) | Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis | |
| DE69434002D1 (de) | 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis | |
| ATE173921T1 (de) | Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen | |
| DE3688787D1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
| DE69433923D1 (de) | Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis | |
| CN1048893C (zh) | 一种治疗骨质增生药油及制作方法 | |
| RU2858379C1 (ru) | Средство для лечения ксеростомии | |
| ATE192650T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
| CN1105243A (zh) | 甲癣灵 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1107766 Country of ref document: EP |